- Events
27/10/2026
Meet TransCure bioServices at ESGCT 2026 in Hamburg
From October 27–30, 2026, TransCure bioServices will be attending the 33rd ESGCT Annual Congress in Hamburg, Germany.
The event brings together researchers, scientists, and industry leaders to explore the latest advances in gene and cell therapies and discuss new approaches to therapeutic development.
Visit us at booth C-10
If you are attending ESGCT 2026, come and meet Samar Chaanine, Head of Commercial Strategy and Development, and Chloé Bonnot, Field Application Scientist, at booth C-10.
Discover how TransCure bioServices can support your preclinical gene and cell therapy programs through:
- Humanized mouse models to investigate human-specific biological responses
- In vivo evaluation of gene and cell therapies in a human-relevant context
- Immunology and immune response assessment to better understand therapeutic activity
- Tailored preclinical studies adapted to your therapeutic candidates and development objectives
Our team combines advanced humanized models with scientific expertise to help you select the most relevant in vivo approach for your research.
Let’s discuss your next preclinical program
Developing a new gene or cell therapy? Looking for a preclinical model that better reflects human biology?
Our team would be happy to discuss your challenges and explore how TransCure bioServices can support your next development steps.
Visit us at booth C-10 and meet Samar and Chloé in Hamburg!
